- Home
- YETI vs MLTX Comparison
YETI vs MLTX Comparison
Compare YETI & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YETI
- MLTX
- Stock Information
- Founded
- YETI 2006
- MLTX 2021
- Country
- YETI United States
- MLTX Switzerland
- Employees
- YETI N/A
- MLTX N/A
- Industry
- YETI Recreational Games/Products/Toys
- MLTX Biotechnology: Pharmaceutical Preparations
- Sector
- YETI Consumer Discretionary
- MLTX Health Care
- Exchange
- YETI Nasdaq
- MLTX Nasdaq
- Market Cap
- YETI 2.5B
- MLTX 2.8B
- IPO Year
- YETI 2018
- MLTX N/A
- Fundamental
- Price
- YETI $37.26
- MLTX $50.46
- Analyst Decision
- YETI Buy
- MLTX Strong Buy
- Analyst Count
- YETI 16
- MLTX 7
- Target Price
- YETI $40.33
- MLTX $73.33
- AVG Volume (30 Days)
- YETI 2.4M
- MLTX 476.7K
- Earning Date
- YETI 08-07-2025
- MLTX 08-11-2025
- Dividend Yield
- YETI N/A
- MLTX N/A
- EPS Growth
- YETI 4.22
- MLTX N/A
- EPS
- YETI 2.08
- MLTX N/A
- Revenue
- YETI $1,839,607,000.00
- MLTX N/A
- Revenue This Year
- YETI $4.93
- MLTX N/A
- Revenue Next Year
- YETI $5.31
- MLTX N/A
- P/E Ratio
- YETI $17.81
- MLTX N/A
- Revenue Growth
- YETI 8.38
- MLTX N/A
- 52 Week Low
- YETI $26.61
- MLTX $31.42
- 52 Week High
- YETI $45.25
- MLTX $58.26
- Technical
- Relative Strength Index (RSI)
- YETI 60.22
- MLTX 50.07
- Support Level
- YETI $36.71
- MLTX $52.65
- Resistance Level
- YETI $39.83
- MLTX $55.91
- Average True Range (ATR)
- YETI 1.40
- MLTX 2.39
- MACD
- YETI 0.26
- MLTX -0.32
- Stochastic Oscillator
- YETI 69.76
- MLTX 37.51
About YETI YETI Holdings Inc.
YETI Holdings Inc is a designer, marketer, and distributor of premium products for the outdoor and recreation market sold under the YETI brand. The company offers products including coolers and equipment, drinkware, and other accessories. Its trademark products include YETI Tundra, Hopper, YETI TANK, Rambler, Colster, Rambler among others. The company distributes products through wholesale channels and through direct-to-consumer, or DTC, channels.
About MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.